Jeremy Grantham Viatris Inc Transaction History

Grantham, Mayo, Van Otterloo & Co. LLC

$31.8 Billion
Q2 2025

A detailed history of Jeremy Grantham (Grantham, Mayo, Van Otterloo & Co. LLC) transactions in Viatris Inc stock. As of the latest transaction made, Grantham, Mayo, Van Otterloo & Co. LLC holds 445,161 shares of VTRS stock, worth $4.7 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

445,161

Previous 2,880,677 84.55%

Holding current value

$4.7 Million

Previous $25.1 Million 84.16%

% of portfolio

0.01%

Previous 0.08%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 13, 2025	SELL	$7.26 - $9.12 $17.7 Million - $22.2 Million	-2,435,516 Reduced 84.55%	445,161 $3.98 Million
Q1 2025 May 14, 2025	BUY	$8.68 - $12.42 $2.91 Million - $4.16 Million	335,123 Added 13.17%	2,880,677 $25.1 Million
Q4 2024 Feb 13, 2025	SELL	$11.32 - $13.37 $11.4 Million - $13.4 Million	-1,004,312 Reduced 28.29%	2,545,554 $31.7 Million
Q3 2024 Nov 13, 2024	BUY	$10.32 - $12.13 $5.43 Million - $6.38 Million	526,341 Added 17.41%	3,549,866 $41.2 Million
Q2 2024 Aug 13, 2024	SELL	$10.05 - $12.02 $5.17 Million - $6.18 Million	-514,378 Reduced 14.54%	3,023,525 $32.1 Million
Q1 2024 May 14, 2024	SELL	$11.27 - $13.53 $6.93 Million - $8.32 Million	-614,836 Reduced 14.81%	3,537,903 $42.2 Million
Q4 2023 Feb 13, 2024	BUY	$8.77 - $10.85 $5.1 Million - $6.31 Million	581,574 Added 16.29%	4,152,739 $45 Million
Q3 2023 Nov 13, 2023	BUY	$9.59 - $11.35 $1.88 Million - $2.22 Million	195,651 Added 5.8%	3,571,165 $35.2 Million
Q2 2023 Aug 14, 2023	SELL	$9.02 - $10.29 $4.45 Million - $5.08 Million	-493,280 Reduced 12.75%	3,375,514 $33.7 Million
Q1 2023 May 12, 2023	BUY	$9.2 - $12.26 $1.74 Million - $2.32 Million	189,500 Added 5.15%	3,868,794 $37.2 Million
Q4 2022 Feb 13, 2023	BUY	$8.72 - $11.56 $5.64 Million - $7.48 Million	647,094 Added 21.34%	3,679,294 $41 Million
Q3 2022 Nov 10, 2022	BUY	$8.48 - $11.13 $3.38 Million - $4.43 Million	398,400 Added 15.13%	3,032,200 $25.8 Million
Q2 2022 Aug 12, 2022	BUY	$9.95 - $12.27 $1.08 Million - $1.34 Million	109,000 Added 4.32%	2,633,800 $27.6 Million
Q1 2022 May 13, 2022	BUY	$9.81 - $15.4 $7.4 Million - $11.6 Million	754,100 Added 42.59%	2,524,800 $27.5 Million
Q4 2021 Feb 11, 2022	SELL	$12.09 - $14.68 $1.6 Million - $1.94 Million	-132,400 Reduced 6.96%	1,770,700 $24 Million
Q3 2021 Nov 12, 2021	BUY	$13.25 - $15.13 $3.87 Million - $4.42 Million	292,400 Added 18.15%	1,903,100 $25.8 Million
Q2 2021 Aug 12, 2021	BUY	$12.97 - $16.15 $4.01 Million - $4.99 Million	308,911 Added 23.73%	1,610,700 $23 Million
Q1 2021 May 13, 2021	BUY	$13.59 - $18.54 $8.75 Million - $11.9 Million	644,032 Added 97.91%	1,301,789 $18.2 Million
Q4 2020 Feb 12, 2021	BUY	$14.3 - $18.74 $9.41 Million - $12.3 Million	657,757 New	657,757 $12.3 Million

Others Institutions Holding VTRS

# of Institutions

1,128

Shares Held

987M

Call Options Held

7.62M

Put Options Held

2.97M

View Full List

About Viatris Inc

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $12.8B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

More about VTRS

Track Jeremy Grantham's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Grantham, Mayo, Van Otterloo & Co. LLC, based on Form 13F filings with the SEC.

News

Stay updated on Grantham, Mayo, Van Otterloo & Co. LLC and Jeremy Grantham with notifications on news.

Account